Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
ADMA Biologics, Inc. (ADMA - Free Report) is a biopharmaceutical and specialty immunoglobulin company. The Zacks Consensus Estimate for its current year earnings has been revised 3.5% downward over the last 30 days.
Phillips 66 Partners LP is an owner and operator of midstream assets. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 30 days.
Everest Re Group, Ltd. is a provider of reinsurance and insurance products. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.
Host Hotels & Resorts, Inc. (HST - Free Report) is a lodging real estate investment trust and owner of luxury and upper-upscale hotels. The Zacks Consensus Estimate for its current year earnings has been revised 33.3% downward over the last 30 days.
AMC Entertainment Holdings, Inc. (AMC - Free Report) is involved in the theatrical exhibition business and operates approximately 1,000 theatres and 11,000 screens in the United States and globally. The Zacks Consensus Estimate for its current year earnings has been revised 16.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
ADMA Biologics, Inc. (ADMA - Free Report) is a biopharmaceutical and specialty immunoglobulin company. The Zacks Consensus Estimate for its current year earnings has been revised 3.5% downward over the last 30 days.
Phillips 66 Partners LP is an owner and operator of midstream assets. The Zacks Consensus Estimate for its current year earnings has been revised 3.3% downward over the last 30 days.
Everest Re Group, Ltd. is a provider of reinsurance and insurance products. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.
Host Hotels & Resorts, Inc. (HST - Free Report) is a lodging real estate investment trust and owner of luxury and upper-upscale hotels. The Zacks Consensus Estimate for its current year earnings has been revised 33.3% downward over the last 30 days.
AMC Entertainment Holdings, Inc. (AMC - Free Report) is involved in the theatrical exhibition business and operates approximately 1,000 theatres and 11,000 screens in the United States and globally. The Zacks Consensus Estimate for its current year earnings has been revised 16.3% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on HST - FREE
Get the latest research report on AMC - FREE
Get the latest research report on ADMA - FREE